Results 61 to 70 of about 9,317,540 (259)
Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy [PDF]
BackgroundGraves' disease (GD) is an autoimmune thyroid disorder caused by antibodies stimulating the thyrotropin (TSH) receptor. TSH receptor antibody (TRAb) measurement is useful for predicting GD relapse after antithyroid drug (ATD) treatment. However,
Yun Mi Choi+3 more
doaj +1 more source
The aim of the study was to estimate a level of thyrotropin-receptor antibodies (TRAb), some cytokines (TNF-α, IL-8, IL-10) in Graves' disease patients with chronic heart failure (CHF) and to reveal prognostic factors of CHF.89 patients with Graves ...
doaj +1 more source
Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy
The course and pathogenesis of Graves’ disease and Graves’ ophthalmopathy are interdependent, influencing each other’s therapeutic choices. Multiple factors including geographic location, access to medical services, patient and physician preferences ...
A. Kotwal, M. Stan
semanticscholar +1 more source
A Case of Graves’ Disease Accompanied with Acute Hepatitis A Virus Infection
Concurrent presentation of acute hepatitis A virus (HAV) infection and Graves’ disease has not been reported in literature worldwide. Although there is no well-established mechanism that explains the induction of Graves’ disease by HAV to date, our case ...
Seong Eun Hong+7 more
doaj +1 more source
Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study.
BACKGROUND Graves' disease (GD) is associated with excess morbidity and mortality, but little is known about unnatural manners of death and the potential relation with Graves' orbitopathy (GO).
Charlotte Ferløv-Schwensen+2 more
semanticscholar +1 more source
BACKGROUND Current surgical indications for Graves' disease include intractability to medical and/or radioablative therapy, compressive symptoms, and worsening ophthalmopathy.
G. Rubio+5 more
semanticscholar +1 more source
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
T. Hoang, D. Stocker, E. Chou, H. Burch
semanticscholar +1 more source